Glucotrack (GCTK) Current Assets (2010 - 2026)

Glucotrack (GCTK) has reported Current Assets for 17 consecutive years, with $1.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Current Assets fell 86.3% year-over-year to $1.4 million; the trailing twelve-month figure through Jun 2026 stood at $1.4 million (down 86.3% YoY), and the FY2025 full-year result was $7.7 million, up 32.92% from the prior year.
• Current Assets slipped to $1.4 million in Q2 2026 per GCTK's latest filing, from $7.7 million in the prior quarter.
• Across five years, Current Assets topped out at $10.1 million in Q2 2025 and bottomed at $442000.0 in Q2 2024.
• Historically, Current Assets has averaged $4.9 million across 5 years, with a median of $4.9 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Current Assets plunged 95.06% in 2024, then soared 2179.86% in 2025.
• Over 5 years, Current Assets stood at $2.4 million in 2022, then surged by 104.62% to $4.9 million in 2023, then advanced by 18.49% to $5.8 million in 2024, then soared by 32.92% to $7.7 million in 2025, then slumped by 81.99% to $1.4 million in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $1.4 million, $7.7 million, and $8.1 million for Q2 2026, Q4 2025, and Q3 2025 respectively.